<DOC>
	<DOCNO>NCT01916148</DOCNO>
	<brief_summary>This purpose study determine ability 18F-fluoro-L-dihydroxyphenylalanine ( 18F-DOPA ) PET scan detect focal lesion hyperinsulinism determine location patient congenital hyperinsulinism , Beckwith Wiedemann Syndrome suspect insulinoma . Safety data collect .</brief_summary>
	<brief_title>18F-L-Fluoro-DOPA PET/CT Scan Localization Focal Pancreatic Lesions Subjects With Hyperinsulinemic Hypoglycemia</brief_title>
	<detailed_description />
	<mesh_term>Hypoglycemia</mesh_term>
	<mesh_term>Hyperinsulinism</mesh_term>
	<mesh_term>Congenital Hyperinsulinism</mesh_term>
	<mesh_term>Insulinoma</mesh_term>
	<mesh_term>Beckwith-Wiedemann Syndrome</mesh_term>
	<criteria>Subjects age hyperinsulinemic hypoglycemia , diagnose fasting test and/or response glucagon stimulation . Subjects eligible pancreatic surgery regardless prior pancreatic surgery Pregnant lactating females Any major illness condition investigator 's judgment substantially increase risk associate subject 's participation study Subjects candidate pancreatic surgery</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Hypoglycemia</keyword>
	<keyword>Hyperinsulinism</keyword>
</DOC>